Chemomab Therapeutics Ltd. American Depositary Share Share Price
NASDAQ: CMMB | Small CapChemomab Therapeutics Ltd. American Depositary Share Stock Performance
Open $2.75 | Prev. Close $2.69 | Circuit Range N/A |
Day Range $2.70 - $2.84 | Year Range $1.39 - $3.59 | Volume 1,201 |
Average Traded $2.75 |
Chemomab Therapeutics Ltd. American Depositary Share Share Price Today
As of 30 August 2026, Chemomab Therapeutics Ltd. American Depositary Share's share price is $2.70. The stock opened at $2.75, compared to its previous close of $2.69. During today's trading session, Chemomab Therapeutics Ltd. American Depositary Share's share price traded between $2.70 and $2.84, with an average price of $2.77. Over the past 52 weeks, the stock has recorded a high of $3.59 and a low of $1.39. In terms of performance, Chemomab Therapeutics Ltd. American Depositary Share's share price has risen by 51.69% over the last six months and is down 13.74% on a year-on-year basis.
Chemomab Therapeutics Ltd. American Depositary Share Share Price Chart
Chemomab Therapeutics Ltd. American Depositary Share Stock Fundamentals & Key Indicators
Market Cap $614.49M | PE Ratio (TTM) 22.50 | Dividend Yield N/A |
EPS (TTM) $0.12 | Revenue (TTM) N/A | Return On Equity (TTM) -76.32% |
Profit Margin N/A | Debt to Equity 0.19 | Quarterly Earnings Growth YoY -71.49% |
Chemomab Therapeutics Ltd. American Depositary Share Quarterly Profit & Loss
All figures in USD
Chemomab Therapeutics Ltd. American Depositary Share Annual Profit & Loss
All figures in USD
About Chemomab Therapeutics Ltd. American Depositary Share
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
Chemomab Therapeutics Ltd. American Depositary Share Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.60 | $2.69 | +74.68% |
Jul 2026 | $1.73 | $1.54 | -3.14% |
Jun 2026 | $2.00 | $1.59 | -20.70% |
May 2026 | $1.57 | $2.00 | +35.47% |
Apr 2026 | $1.58 | $1.48 | -1.33% |
Mar 2026 | $1.85 | $1.50 | -15.73% |
Feb 2026 | $1.58 | $1.78 | +14.84% |
Jan 2026 | $1.76 | $1.55 | -5.49% |
Dec 2025 | $2.64 | $1.64 | -36.80% |
Nov 2025 | $3.00 | $2.60 | -15.88% |
Oct 2025 | $2.65 | $3.08 | +15.11% |
Sep 2025 | $3.17 | $2.68 | -14.38% |
CMMB Share Price FAQs
What is Chemomab Therapeutics Ltd. American Depositary Share share price today?
What is the 52 week high and 52 week low of Chemomab Therapeutics Ltd. American Depositary Share stock?
What is CMMB's market capitalisation today?
What is CMMB's net income for the last quarter?
What is the 5 year returns of CMMB?
What is the high & low stock price of CMMB today?
Can I buy CMMB shares in India?